查爾斯河實驗室 CRL 深 滬
等待開盤 11-26 09:30:00 美东时间
178.05
+7.610
+4.46%
華盛通- 最 高178.55
- 今 開170.51
- 成交量 78.95万股
- 最 低 170.51
- 昨 收 170.44
- 總市值 87.63亿
- 52周最高 202.72
- 市盈率 靜 892.93
- 換手率 1.60%
- 52周最低 91.8609
- 委 比 0.00%
- 總股本 4921.42万
- 歷史最高 460.21
- 量 比 0.69
- 振 幅 4.72%
- 歷史最低 25.52
- 每 手 1
- 風險率 21.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多'CDC to end all monkey research; Studies Related To HIV And Other Infectious Diseases Will Be Phased Out, Sources Say; Fate Of The Agency's Animals Remains Unclear'- Science
https://www.science.org/content/article/exclusive-cdc-end-all-monkey-research
11-22 02:33
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Baird Upgrades Charles River to Outperform, Raises Price Target to $199
Baird analyst Eric Coldwell upgrades Charles River (NYSE:CRL) from Neutral to Outperform and raises the price target from $178 to $199.
11-06 19:49
Charles River Beat Expectations But Why Is The Stock Falling?
Charles River stock dips as Q3 revenue slips, EPS beats estimates, and company raises 2025 outlook with cost cuts and $1 billion buyback plan.
11-06 02:38
Charles River Lowers FY2025 GAAP EPS Guidance from $4.25-$4.65 to $4.15-$4.35 vs $4.57 Est
The Company's 2025 guidance for revenue and earnings per share is as follows:2025 GUIDANCECURRENTPRIORRevenue growth/(decrease), reported(1.5)% – (0.5)%(2.5)% – (0.5)%Impact of divestitures/(acquisitions),
11-05 20:08
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
Circle是什么？CRCL股价走势如何？ CRCL股票值得投资？
Circle Internet Financial（简称「Circle」） 是一家美国金融科技公司，成立初期从事P2P 支付与跨境支付产品（Circle Pay），曾经短暂涉足加密货币交易平台业务。目前，Circle已经转向数位资产基础设施供应商，聚焦稳定币业务。
10-29 08:48
Unicycive Therapeutics Plans To Resubmit NDA For Oxylanthanum Carbonate By Year-End
Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the Company or Unicycive), today announced an update from its meeting with the
10-28 19:10
